期刊
JOURNAL OF CLINICAL IMMUNOLOGY
卷 27, 期 1, 页码 19-35出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-006-9066-7
关键词
curcumin; tumor necrosis factor; nuclear factor-kappa B; interleukins; chemokines; immunomodulation
类别
资金
- NCI NIH HHS [CA16672, P50CA97007, P01CA91844] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [P50CA097007, P01CA091844, P30CA016672] Funding Source: NIH RePORTER
Curcumin (diferuloylmethane) is an orange-yellow component of turmeric (Curcuma longa), a spice often found in curry powder. Traditionally known for its an antiinflammatory effects, curcumin has been shown in the last two decades to be a potent immunomodulatory agent that can modulate the activation of T cells, B cells, macrophages, neutrophils, natural killer cells, and dendritic cells. Curcumin can also downregulate the expression of various proinflammatory cytokines including TNF, IL-1, IL-2, IL-6, IL-8, IL-12, and chemokines, most likely through inactivation of the transcription factor NF-kappa B. Interestingly, however, curcumin at low doses can also enhance antibody responses. This suggests that curcumin's reported beneficial effects in arthritis, allergy, asthma, atherosclerosis, heart disease, Alzheimer's disease, diabetes, and cancer might be due in part to its ability to modulate the immune system. Together, these findings warrant further consideration of curcumin as a therapy for immune disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据